2003
DOI: 10.1074/jbc.m301339200
|View full text |Cite
|
Sign up to set email alerts
|

Dok-R Binds c-Abl and Regulates Abl Kinase Activity and Mediates Cytoskeletal Reorganization

Abstract: Dok-R, also known as Dok-2/FRIP, belongs to the DOK family of signaling molecules that become tyrosinephosphorylated by several different receptor and cytoplasmic tyrosine kinases. Tyrosine phosphorylation of DOK proteins establishes high affinity binding sites for other signaling molecules leading to activation of a signaling cascade. Here we show that Dok-R associates with c-Abl directly via a constitutive SH3-mediated interaction and that this binding requires a PMMP motif in the proline-rich tail of Dok-R.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
24
0

Year Published

2006
2006
2017
2017

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 30 publications
(25 citation statements)
references
References 49 publications
(53 reference statements)
1
24
0
Order By: Relevance
“…Because c-Abl is implicated in B-cell receptor signaling, this kinase could then, in turn, be at least partly responsible for some of the effects of this signaling. If so, our experiments showing that STI-571 inhibits c-Abl-induced phosphorylation of DOK2, a known c-Abl substrate (23), support the proposition that, in unmutated CLL, signals from the B-cell receptor provide cell rescue from apoptosis (1,27). Such rescue includes an activation of NF-nB that partly depends on constitutively active c-Abl.…”
Section: Discussionsupporting
confidence: 62%
See 1 more Smart Citation
“…Because c-Abl is implicated in B-cell receptor signaling, this kinase could then, in turn, be at least partly responsible for some of the effects of this signaling. If so, our experiments showing that STI-571 inhibits c-Abl-induced phosphorylation of DOK2, a known c-Abl substrate (23), support the proposition that, in unmutated CLL, signals from the B-cell receptor provide cell rescue from apoptosis (1,27). Such rescue includes an activation of NF-nB that partly depends on constitutively active c-Abl.…”
Section: Discussionsupporting
confidence: 62%
“…This shows that STI-571 was an effective inhibitor of c-Abl in intact cells. DOK2 is a known substrate of active c-Abl in hemopoietic cells (23) and its phosphorylation on tyrosine was used as a measure of c-Abl activity in KCL22 and CLL cells. Figure 4B shows that treatment of these cells with 10 Amol/L STI-571 markedly reduced the phosphorylation of DOK2, suggesting that STI-571 also inhibits c-Abl activity in intact CLL cells.…”
Section: C-abl Is Variably Expressed In the Malignant Cells Of Cllmentioning
confidence: 99%
“…Protrusion formation similar to that induced by ORP3 has been reported to occur upon overexpression of several other proteins, all of which represent regulators of the actin cytoskeleton: Cdc42 effector protein 1 (CEP1/MSE55) (Burbelo et al, 1999), ATPbinding cassette transporter-1 (ABCA1) (Wang, N. et al, 2000;Tsukamoto et al, 2001), calpain 2 (CAPN2) (Franco et al, 2004;Perrin et al, 2006), downstream of kinase 2 (Dok-2, Dok-R or FRIP) (Master et al, 2003) and c-Abl tyrosine kinase (Master et al, 2003). Dok-2 and c-Abl represent proteins associated with Nck (Master et al, 2001;Master et al, 2003), which is involved in the regulation of R-Ras function (Wang, B. et al, 2000) and the actin cytoskeleton (Buday et al, 2002).…”
Section: Journal Of Cell Science 121 (5)mentioning
confidence: 99%
“…Dok-2 and c-Abl represent proteins associated with Nck (Master et al, 2001;Master et al, 2003), which is involved in the regulation of R-Ras function (Wang, B. et al, 2000) and the actin cytoskeleton (Buday et al, 2002). Nck binds to Wiskott-Aldrich syndrome protein (WASP), which controls the nucleation of actin filaments by the Arp2/3 complex (Buday et al, 2002).…”
Section: Journal Of Cell Science 121 (5)mentioning
confidence: 99%
“…Abl exists in an inactive autoinhibited state in which the SH3 and SH2 domains bind through intramolecular interactions to the kinase domain and function as a "clamp" to maintain a conformer of low catalytic activity (37). Release of the SH3-SH2 domain from the kinase domain through competing occupancy of the SH3 and SH2 domains by cognate ligands in-trans results in efficient activation of Abl (38)(39)(40). Phosphorylation of tyrosine 412 (Y 412 ) (41) in the activation helix and tyrosine 245 (Y 245 ) (42) in the kinase-SH2 linker sequence were associated with a state of high Abl kinase activity.…”
Section: Figurementioning
confidence: 99%